Rouet-Benzineb, P., Rouyer-Fessard, C., Jarry, A., Avondo, V., Pouzet, C., Yanagisawa, M., Laboisse, C., Laburthe, M. and Voisin, T.
Notes: Human colon cancer (HT29-D4) cells were analyzed for activated caspases using the CaspACE™ FITC-VAD-FMK In Situ Marker. HT29-D4 cells (7 x 105) were cultured in the presence or absence of 1µM orexins, peptide growth inhibitors. Cells were washed, and bound CaspACE™ FITC-VAD-FMK In Situ Marker was visualized by confocal microscopy. (3255)